Why the study?
Does total body irradiation-based hematopoietic cell transplantation increase the risk of adverse cardiometabolic traits in pediatric survivors of acute lymphoblastic leukemia compared to conventional chemotherapy?
Does total body irradiation-based hematopoietic cell transplantation increase the risk of adverse cardiometabolic traits in pediatric survivors of acute lymphoblastic leukemia compared to conventional chemotherapy?
Pediatric ALL survivors treated with TBI-based HCT have a significantly higher risk of developing early cardiometabolic traits and metabolic syndrome compared to those treated with conventional chemotherapy, warranting early screening.
No takes yet. Share an insight, caveat, or question.
Supports heightened cardiometabolic surveillance in HCT-treated pediatric ALL survivors; leaves open causal role of TBI and need for prospective validation.
Chow et al. (2010) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: